Casdin Capital’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-20,000
Closed -$3.47M 40
2018
Q2
$3.47M Buy
+20,000
New +$3.01M 0.49% 29

Other funds holding LOXO

Casdin Capital's LOXO Position: Q1 2019 in Review

Casdin Capital sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 360,000 shares — an estimated $50.4M sold.

Casdin Capital first reported a position in LOXO in Q4 2015 and held it in 13 quarters. The position peaked at $62.5M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Casdin Capital reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Casdin Capital sold 360,000 Loxo Oncology, Inc shares in Q1 2019, an estimated $50.4M.
  • Casdin Capital first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 13 quarters.
  • Casdin Capital's Loxo Oncology, Inc position peaked at $62.5M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Casdin Capital's 13F filing for Q1 2019, filed 15 May 2019.